Director Baker Douglas M Jr acquired 15,000 MRK shares at $88.50, raising stake 1500% to 16,000 shares amid -34.4% decline from 52-week high.
Douglas M Baker Jr., a Merck director, purchased 15,000 shares at $88.50 on 2025-02-05, expanding his position from 1,000 shares to 16,000 shares. The transaction occurred when the stock was trading 34.4% below its 52-week high of $132.96 and has declined 12.6% over the past 30 days and 15.2% over 90 days. The 1,327,500.00 dollar commitment to increase holdings by 1500% represents material personal capital allocation by a director during a period of recent downward price momentum. Merck's latest quarter revenues are $16.7B with net income of $3.2B, and the stock trades at a P/E of 18.18 with a market cap of $220.8B. The transaction alone does not signal a broader board-level capital reallocation and should be evaluated alongside other governance and operational developments at the company.